Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice

PDF) Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo

Lifestyle effects on hematopoiesis and atherosclerosis. - Abstract - Europe PMC

Frontiers Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies

PDF) Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo

Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system - ScienceDirect

PDF) CC Chemokine Receptors and Chronic Inflammation-Therapeutic Opportunities and Pharmacological Challenges

Annette GRAHAM, Professor, Vascular Cell Biology, PhD, Glasgow Caledonian University, Glasgow, GCU, Department of Life Sciences

Chemokines: A Potential Therapeutic Target for the Stabilisation of Vulnerable Plaque - European Medical Journal

Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease

Chemokines as Therapeutic Targets in Cardiovascular Disease

Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice

IJMS, Free Full-Text